We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

98 hedge funds and large institutions have $287M invested in Akcea Therapeutics Inc in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 19

21% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 24

17% more funds holding

Funds holding: 84 → 98 (+14)

7% more capital invested

Capital invested by funds: $268M → $287M (+$19M)

78% less call options, than puts

Call options by funds: $553K | Put options by funds: $2.47M

Holders
98
Holders Change
+14
Holders Change %
+16.67%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
29
Reduced
24
Closed
19
Calls
$553K
Puts
$2.47M
Net Calls
-$1.92M
Net Calls Change
-$1.76M

Top Buyers

Rank Fund Capital Flow
1
GF
Gabelli Funds
New York
+$8.51M
2
Wells Fargo
Wells Fargo
California
+$5.48M
3
CS
Credit Suisse
Switzerland
+$5.35M
4
CS
Candriam SCA
Luxembourg
+$3.47M
5
WIC
Water Island Capital
New York
+$3.09M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$69.4M
2
BG
Bellevue Group
Switzerland
-$15.9M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.53M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$3.19M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
101
PDT Partners
New York
– -$543K -39,616 Closed
Arrowstreet Capital
102
Arrowstreet Capital
Massachusetts
– -$376K -27,451 Closed
VRS
103
Virginia Retirement Systems
Virginia
– -$303K -22,100 Closed
Prudential Financial
104
Prudential Financial
New Jersey
– -$262K -19,087 Closed
AIM
105
Aigen Investment Management
New York
– -$256K -18,676 Closed
HW
106
Hancock Whitney
Mississippi
– -$226K -16,481 Closed
Skandinaviska Enskilda Banken (SEB)
107
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$189K -13,800 Closed
AC
108
Amia Capital
United Kingdom
– -$189K -13,761 Closed
UBS AM
109
UBS AM
Illinois
– -$166K -12,084 Closed
CMBA
110
C.M. Bidwell & Associates
Hawaii
– -$146K -10,660 Closed
CSS
111
Cubist Systematic Strategies
Connecticut
– -$51K -3,700 Closed
RA
112
Royce & Associates
New York
– -$29K -2,152 Closed
PHK
113
Point72 Hong Kong
Hong Kong
– -$17K -1,266 Closed
MAM
114
Meeder Asset Management
Ohio
– -$12K -813 Closed
CFA
115
Carroll Financial Associates
North Carolina
– -$3K -275 Closed
FIA
116
FNY Investment Advisers
New York
– +$71 +5 New
1 2 3 4
5

AKCA Hedge Fund Activity: Q3 2020 in Review

98 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q3 2020, worth a combined $287M — up 7.1% from $268M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new AKCA positions and 19 closed out — a net gain of 14 holders — while 29 added to existing stakes and 24 trimmed.

The largest buyer was Gabelli Funds, opening a new position worth an estimated $8.51M. The largest seller was Fidelity Investments, cutting an estimated $69.4M.

  • 98 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q3 2020, up from 84 in Q2 2020.
  • Funds reported $287M of Akcea Therapeutics Inc stock for Q3 2020, up 7.1% quarter-over-quarter.
  • 33 funds opened new Akcea Therapeutics Inc positions in Q3 2020 and 19 closed out, a net change of +14 holders.
  • The largest Akcea Therapeutics Inc buyer in Q3 2020 was Gabelli Funds, an estimated $8.51M added.
  • The largest Akcea Therapeutics Inc seller in Q3 2020 was Fidelity Investments, an estimated $69.4M sold.

Based on aggregated 13F filings for Q3 2020.